Metal chaperones: a holistic approach to the treatment of Alzheimer's disease - Test2 - elhamkhani - TriplyDB

Metal chaperones: a holistic approach to the treatment of Alzheimer's disease

Metal chaperones: a holistic approach to the treatment of Alzheimer's disease

http://www.wikidata.org/entity/Q34260002

about

Spatial memory deficits in a mouse model of late-onset Alzheimer's disease are caused by zinc supplementation and correlate with amyloid-beta levels Clioquinol synergistically augments rescue by zinc supplementation in a mouse model of acrodermatitis enteropathica Supplementation with zinc in rats enhances memory and reverses an age-dependent increase in plasma copper.Trehalose Improves Cognition in the Transgenic Tg2576 Mouse Model of Alzheimer's Disease.Metals and Alzheimer's Disease: How Far Have We Come in the Clinic?

P2860

Q34384925-6CAE3B96-2E88-4F2E-8914-AF2272C3C7BD Q34981544-8F409773-B0B4-4D18-926F-4F6419E5DA73 Q38685683-A9113333-50F5-43B9-BBCD-9A09268264D3 Q41852404-C64A4FF2-DFF9-49C4-A54A-D10DE0090CE7 Q51760893-1F8B7877-C579-43EC-8075-8C07FF124FB5

P2860

Metal chaperones: a holistic approach to the treatment of Alzheimer's disease

http://www.wikidata.org/entity/Q34260002

description

2012 nî lūn-bûn

@nan

2012 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի մարտին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Metal chaperones: a holistic approach to the treatment of Alzheimer's disease

@ast

Metal chaperones: a holistic approach to the treatment of Alzheimer's disease

@en

Metal chaperones: a holistic approach to the treatment of Alzheimer's disease

@nl

type

label

Metal chaperones: a holistic approach to the treatment of Alzheimer's disease

@ast

Metal chaperones: a holistic approach to the treatment of Alzheimer's disease

@en

Metal chaperones: a holistic approach to the treatment of Alzheimer's disease

@nl

prefLabel

Metal chaperones: a holistic approach to the treatment of Alzheimer's disease

@ast

Metal chaperones: a holistic approach to the treatment of Alzheimer's disease

@en

Metal chaperones: a holistic approach to the treatment of Alzheimer's disease

@nl

P1433

Q34260002-AD5EDDA9-ED88-4F3B-921E-B1060FEBB6BD

P1476

Q34260002-299DEBAC-A8A7-4225-ADDD-933D1B039AE9

P2093

Q34260002-1655BBEC-5895-46D7-B40B-49A201AF48CB

P2860

Q34260002-00A0CF3A-51EC-4453-A436-4DE7E0510291

Q34260002-08C9DE92-2906-4AFE-A98E-4220C8D3E4E0

Q34260002-11C91687-415C-4F9B-9055-7C1733FC7618

Q34260002-18121487-C6AD-4DAD-AE0B-0B6ADF03071B

Q34260002-2353DADF-EDC3-44A0-8462-19F01E9712D4

Q34260002-2BC94EA4-1A22-4819-9925-37DB7241A28E

Q34260002-491681C3-2688-4483-AF5D-126CB2D79524

Q34260002-4B18B9E1-7FF9-4E5F-A679-ED993324D761

Q34260002-4B50F6FD-03CC-4E4E-8267-F7BECAB2A8F5

Q34260002-520E6C04-4DDE-4C0F-B02B-B627B5D143AD

P304

Q34260002-16A9F7D4-C4AD-4C1F-8673-32A4CEFA7AF3

P31

Q34260002-C0C6CB5F-1301-4332-B81A-E0D8942CE7AD

P356

Q34260002-A3886B24-ADD1-4B9D-A701-052937361AEB

P478

Q34260002-42066FB7-6C5C-4C4A-89A9-D6A0501D2D8F

P50

Q34260002-AF60BC0F-0842-4B9B-869E-7E29DFF0760D

P577

Q34260002-30E4D27C-154D-4116-ABA3-F4DCD492884C

P5875

Q34260002-54074779-F663-4ED1-80BC-DD7F442C4B15

P698

Q34260002-C4D3D767-14CC-4968-81E7-D0B1709660B7

P921

Q34260002-05BB3E7B-B612-45E0-BE97-F2F80BE70AE3

Q34260002-7C857900-4E60-4AA8-94C5-16F415B48ADC

P932

Q34260002-0E04B095-8738-435C-B9E1-A2654804FD97

P356

FPSYT.2012.00015

P1433

Frontiers in Psychiatry

P1476

Metal chaperones: a holistic approach to the treatment of Alzheimer's disease

@en

P2093

Paul Anthony Adlard

http://www.w3.org/2001/XMLSchema#string

P2860

ZnT-3, a putative transporter of zinc into synaptic vesicles

Contribution by synaptic zinc to the gender-disparate plaque formation in human Swedish mutant APP transgenic mice

Elimination of zinc from synaptic vesicles in the intact mouse brain by disruption of the ZnT3 gene

Testing the right target and right drug at the right stage

Metal ionophore treatment restores dendritic spine density and synaptic protein levels in a mouse model of Alzheimer's disease

The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics

Redox metals and neurodegenerative disease.

Dietary Cu stabilizes brain superoxide dismutase 1 activity and reduces amyloid Abeta production in APP23 transgenic mice

In vivo reduction of amyloid-beta by a mutant copper transporter

Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system--too little activation is bad, too much is even worse.

P304

15

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FPSYT.2012.00015

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-03-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221689433

http://www.w3.org/2001/XMLSchema#string

P698

22403554

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

molecular chaperones

P932

3291880

http://www.w3.org/2001/XMLSchema#string